COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children's Haematology/Oncology Group consensus statement.

MLA

Furlong, Eliska, et al. “COVID-19 Vaccination in Children and Adolescents Aged 5 Years and Older Undergoing Treatment for Cancer and Non-Malignant Haematological Conditions: Australian and New Zealand Children’s Haematology/Oncology Group Consensus Statement.” The Medical Journal of Australia, vol. 216, no. 6, Apr. 2022, pp. 312–19. EBSCOhost, https://doi.org/10.5694/mja2.51444.

APA

Furlong, E., Kotecha, R. S., Conyers, R., O’Brien, T. A., Hansford, J. R., Super, L., Downie, P., Eisenstat, D. D., Haeusler, G., McMullan, B., Phillips, M. B., Padhye, B., Dalla-Pozza, L., Alvaro, F., Fraser, C. J., Nicholls, W., Clark, J. E., O’Connor, M., Saxon, B. R., … Gottardo, N. G. (2022). COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children’s Haematology/Oncology Group consensus statement. The Medical Journal of Australia, 216(6), 312–319. https://doi.org/10.5694/mja2.51444

Chicago

Furlong, Eliska, Rishi S Kotecha, Rachel Conyers, Tracey A O’Brien, Jordan R Hansford, Leanne Super, Peter Downie, et al. 2022. “COVID-19 Vaccination in Children and Adolescents Aged 5 Years and Older Undergoing Treatment for Cancer and Non-Malignant Haematological Conditions: Australian and New Zealand Children’s Haematology/Oncology Group Consensus Statement.” The Medical Journal of Australia 216 (6): 312–19. doi:10.5694/mja2.51444.